Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cognition Therapeutics, Inc

0.4474
+0.03247.81%
Post-market: 0.44740.00000.00%19:58 EDT
Volume:370.67K
Turnover:161.14K
Market Cap:18.59M
PE:-0.47
High:0.4484
Open:0.4300
Low:0.4210
Close:0.4150
Loading ...

Cognition announces all participants completed final visit in SHIMMER study

TIPRANKS
·
26 Nov 2024

Cognition Therapeutics provided an update on Phase 2 ‘SHINE’ study analysis

TipRanks
·
26 Nov 2024

Cognition Therapeutics Announces All Participants Have Completed Their Final Visits in the Phase 2 Shimmer Study of Ct1812 in Dementia With Lewy Bodies

THOMSON REUTERS
·
26 Nov 2024

Cognition Therapeutics Inc -Topline Results in Second Dementia Indication Expected to Be Reported in December 2024

THOMSON REUTERS
·
26 Nov 2024

Cognition Therapeutics Announces all Participants have Completed their Final Visits in the Phase 2 SHIMMER Study of CT1812 in Dementia with Lewy Bodies

GlobeNewswire
·
26 Nov 2024

BRIEF-Cognition Therapeutics’ Analysis Correlates Biomarker Changes With Cognitive Benefit In Alzheimer’S Population

Reuters
·
25 Nov 2024

Cognition Therapeutics’ Analysis Correlates Biomarker Changes With Cognitive Benefit in Alzheimer’s Population

THOMSON REUTERS
·
25 Nov 2024

Cognition Therapeutics’ Analysis Correlates Biomarker Changes with Cognitive Benefit in Alzheimer’s Population

GlobeNewswire
·
25 Nov 2024

Life Sciences Investor Forum: Presentations Now Available for Online Viewing

GlobeNewswire
·
15 Nov 2024

Cognition Therapeutics reports Q3 EPS (25c), consensus (22c)

TIPRANKS
·
13 Nov 2024

Cognition Therapeutics sees cash runway into 2Q25

TIPRANKS
·
13 Nov 2024

Cognition Therapeutics - Qtrly Loss per Share $0.25

THOMSON REUTERS
·
13 Nov 2024

Cognition Therapeutics Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update

GlobeNewswire
·
13 Nov 2024

Life Sciences Investor Forum Agenda Announced for November 14th

GlobeNewswire
·
12 Nov 2024

Cognition Therapeutics to Present at Zacks SCR Life Sciences Investor Forum

GlobeNewswire
·
12 Nov 2024

Cognition Therapeutics (CGTX) Gets a Buy from Oppenheimer

TIPRANKS
·
05 Nov 2024